Page last updated: 2024-12-11

tiglylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tiglylglycine: RN is from 9th CI [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tiglylglycine : An N-acylglycine that is glycine with an amine hydrogen substituted by a 2-methylbut-2-enoyl (tiglyl) group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
GlycinegenusA non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID6441567
CHEBI ID73018
SCHEMBL ID528243
SCHEMBL ID528244
MeSH IDM0044630

Synonyms (29)

Synonym
glycine, n-[(2e)-2-methyl-1-oxo-2-butenyl]-
tiglylglycine
n-[(2e)-2-methyl-1-oxo-2-buten-1-yl]glycine
tiglyl glycine
T1260
35842-45-6
n-tigloylglycine
2-[[(e)-2-methylbut-2-enoyl]amino]acetic acid
glycine, n-(2-methyl-1-oxo-2-butenyl)-, (e)-
n-tiglylglycine
n-[(2e)-2-methylbut-2-enoyl]glycine
CHEBI:73018
mfcd00059118
AKOS025296174
SCHEMBL528243
SCHEMBL528244
glycine, n-[(2e)-2-methyl-1-oxo-2-buten-1-yl]-
WRUSVQOKJIDBLP-HWKANZROSA-N
2-[(2e)-2-methylbut-2-enamido]acetic acid
AS-64540
(e)-n-(2-methyl-1-oxo-2-butenyl)-glycine
n-((e)-2-methyl-but-2-enoyl)-glycine
(e)-2-(2-methylbut-2-enamido)acetic acid
Q22984474
DTXSID801317636
?n-tigloylglycine
CS-W014368
HY-W013652
EF97P3227C
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
N-acylglycineAn N-acyl-amino acid in which amino acid specified is glycine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Leucine, isoleucine and valine metabolism2470

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (40.00)18.7374
1990's4 (20.00)18.2507
2000's2 (10.00)29.6817
2010's5 (25.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.75 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies12 (60.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]